JDD Issue Highlights | June 2022: Acne & Rosacea
The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on bullous dermatitis and low dose Naltrexone in combination with PRP …
The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on bullous dermatitis and low dose Naltrexone in combination with PRP … Continue reading "JDD Issue Highlights | June 2022: Acne & Rosacea"
Dr. Diane Thiboutot, Professor of Dermatology at The Pennsylvania State University College of Medicine, gave a practical talk at the 2022 ODAC Dermatology, Aesthetic and Surgical Conference about hormonal treatment of acne. Dr. Thiboutot discussed the hormonal work up, indications for hormonal treatment, and guidelines for choosing a therapy, including oral contraceptives.
Hormonal Workup for Ac … 
Tomorrow when we arrive into clinic (or this afternoon if you are reading this during your lunch break), we will invariably be greeted with patients who struggle with one of the most common diseases we treat – acne. More than likely, we will reach for topical retinoids, topical antibiotics, and the occasional systemic antibiotic. Evidence supports the short-term use of systemic antibiotics t … 
The following questions were submitted by attendees during the GW Virtual Acne Appraisal Conference held on July 30th, 2020. To watch the on-demand recording of each lecture presented during the conference, click here.
Topical Management of Acne – James Q. Del Rosso, DO, FAOCD
Is there any risk of minocycline foam causing minocycline-induced hyperpigmentation? Or is that more a … 